Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period
Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods: Th...
Saved in:
Published in | Journal of paediatrics and child health Vol. 48; no. 11; pp. 1029 - 1032 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Melbourne, Australia
Blackwell Publishing Asia
01.11.2012
Blackwell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place.
Methods: The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months.
Results: Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis.
Conclusion: The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. |
---|---|
AbstractList | AIMTo evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place.METHODSThe total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6 months of age and non-classical (NC-CAH) as presenting after 6 months.RESULTSOf the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10, 000 live births (1:14, 869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis.CONCLUSIONThe estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods: The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months. Results: Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion: The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods: The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months. Results: Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion: The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods: The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6months of age and non-classical (NC-CAH) as presenting after 6months. Results: Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10000 live births (1:14869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9±2.5days) compared to males (23.4±9.8days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion: The estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. [PUBLICATION ABSTRACT] To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6 months of age and non-classical (NC-CAH) as presenting after 6 months. Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10, 000 live births (1:14, 869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. The estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. |
Author | Shetty, Vinutha B Jones, Timothy W Davis, Elizabeth A Bower, Carol Lewis, Barry D |
Author_xml | – sequence: 1 givenname: Vinutha B surname: Shetty fullname: Shetty, Vinutha B organization: Department of Endocrinology – sequence: 2 givenname: Carol surname: Bower fullname: Bower, Carol organization: Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital – sequence: 3 givenname: Timothy W surname: Jones fullname: Jones, Timothy W organization: Department of Endocrinology – sequence: 4 givenname: Barry D surname: Lewis fullname: Lewis, Barry D organization: Department of Clinical Biochemistry, Path West Laboratory Medicine, Princess Margaret Hospital for Children – sequence: 5 givenname: Elizabeth A surname: Davis fullname: Davis, Elizabeth A email: Elizabeth.Davis@health.wa.gov.au organization: Department of Endocrinology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23039988$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1v1DAQhi1URD_gLyBLXLgk-CuJc-BQVqUFqoJE0R4tJ55QL1lnsRPY_fedsO0eONWXGXmedzzj95QchSEAIZSznON5t8q5UizjVaFywbjImSi0yrfPyMmhcIQ5kypTmrNjcprSijHECv2CHAvJZF1rfULSxXgXfEttcPQnBAeROt91ECG0kKgPNNoRk6Gj7RCQ8KPtqXVYx3i320Dc9DZ5O6NLSCPEQM-nNEbb4-XwBxtaKjjdgY0UaT-4l-R5Z_sErx7iGfnx8eJ2cZVdf738tDi_zlpVKhxcWl455rQrKq063rGmVLKBsmmFBCsUkwV0oJQuZcPKhnPNrNCVqkruBO5-Rt7u-27i8HvC2czapxb63gYYpmQ4V7yQuhAlom_-Q1fDFHHFmZJCl7WSc0O9p9o4pBShM5vo1zbuDGdmNsaszPz_Zv5_Mxtj_hljtih9_fDA1KzBHYSPTiDwfg_89T3sntzYfP62mDPUZ3u9Rw-2B72Nv0xZyaowy5tL8_12WV99KL6YWt4DIBmrgg |
CitedBy_id | crossref_primary_10_1155_2016_5748264 crossref_primary_10_1177_1099800413486340 crossref_primary_10_1016_j_ymgmr_2016_02_005 crossref_primary_10_52727_2078_256X_2022_18_4_426_429 crossref_primary_10_1515_jpem_2020_0681 crossref_primary_10_3389_fped_2021_659492 crossref_primary_10_5694_mja14_00402 crossref_primary_10_1210_jc_2018_01865 crossref_primary_10_1159_000526401 crossref_primary_10_3389_fendo_2023_1102741 crossref_primary_10_1210_endrev_bnab016 crossref_primary_10_1210_jendso_bvz013 crossref_primary_10_1210_jc_2014_3168 |
Cites_doi | 10.1001/archpedi.153.12.1272 10.1542/peds.108.6.1320 10.1007/s00431-003-1311-y 10.1007/s10024-005-0004-0 10.1542/peds.101.4.583 10.1542/peds.101.4.e11 10.1159/000098400 10.1111/j.1440-1754.2008.01383.x 10.1007/s00431-006-0154-8 10.1210/jc.78.2.241 10.1136/adc.70.3.214 10.1515/JPEM.2008.21.5.455 10.1016/S0022-3476(95)70513-9 10.1159/000113023 10.1515/JPEM.2009.22.2.127 10.1016/S0959-8049(03)00152-7 10.1210/jc.2006-0964 10.1210/jc.2002-012093 10.1210/jc.86.7.2958 10.1177/088307389100600404 10.1016/S0929-6646(10)60035-6 10.1159/000082896 10.1159/000110586 10.1590/S0043-31442006000200009 |
ContentType | Journal Article |
Copyright | 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians) 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians). Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians) |
Copyright_xml | – notice: 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians) – notice: 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians). – notice: Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians) |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION ASE FPQ K6X K9. NAPCQ 7X8 |
DOI | 10.1111/j.1440-1754.2012.02584.x |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef British Nursing Index British Nursing Index (BNI) (1985 to Present) British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium British Nursing Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1754 |
EndPage | 1032 |
ExternalDocumentID | 2807544041 10_1111_j_1440_1754_2012_02584_x 23039988 JPC2584 ark_67375_WNG_STW9HB5K_9 |
Genre | article Journal Article Feature |
GeographicLocations | Western Australia Western Australia Australia |
GeographicLocations_xml | – name: Western Australia – name: Western Australia Australia |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIVO ABJNI ABPTK ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHEFC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KTM LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZGI ZXP ZZTAW ~IA ~WT AITYG HGLYW OIG CGR CUY CVF ECM EIF NPM AAYXX CITATION ASE FPQ K6X K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c4644-43a17d0d8d5784f1f0b643be6bc23ea24035efe44863b06b1180a2874761d2103 |
IEDL.DBID | DR2 |
ISSN | 1034-4810 |
IngestDate | Fri Aug 16 10:56:45 EDT 2024 Fri Sep 13 06:53:37 EDT 2024 Fri Aug 23 00:41:38 EDT 2024 Sat Sep 28 08:06:55 EDT 2024 Sat Aug 24 00:54:35 EDT 2024 Wed Jan 17 05:09:09 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4644-43a17d0d8d5784f1f0b643be6bc23ea24035efe44863b06b1180a2874761d2103 |
Notes | ArticleID:JPC2584 ark:/67375/WNG-STW9HB5K-9 istex:9CA42CE2D5325ABBA1497A49B63F2DEAF465E26C Conflict of interest: None declared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23039988 |
PQID | 1132869430 |
PQPubID | 49064 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1141538526 proquest_journals_1132869430 crossref_primary_10_1111_j_1440_1754_2012_02584_x pubmed_primary_23039988 wiley_primary_10_1111_j_1440_1754_2012_02584_x_JPC2584 istex_primary_ark_67375_WNG_STW9HB5K_9 |
PublicationCentury | 2000 |
PublicationDate | November 2012 |
PublicationDateYYYYMMDD | 2012-11-01 |
PublicationDate_xml | – month: 11 year: 2012 text: November 2012 |
PublicationDecade | 2010 |
PublicationPlace | Melbourne, Australia |
PublicationPlace_xml | – name: Melbourne, Australia – name: Australia – name: Oxford |
PublicationTitle | Journal of paediatrics and child health |
PublicationTitleAlternate | J Paediatr Child Health |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Asia Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Asia – name: Blackwell Publishing Ltd |
References | Lee C-T, Tung Y-C, Hsiao P-H, Lee J-S, Tsai W-Y. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era. J. Formos. Med. Assoc. 2010; 109: 148-55. Nass R, Baker S. Learning disabilities in children with congenital adrenal hyperplasia. J. Child Neurol. 1991; 6: 306-12. Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm. Res. 2007; 67: 284-91. Pang SY, Wallace MA, Hofman L et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81: 866-74. Brosnan PG, Brosnan CA, Kemp SF et al. Effect of newborn screening for congenital adrenal hyperplasia. Arch. Pediatr. Adolesc. Med. 1999; 153: 1272-8. Nimkarn S, Lin-Su K, Berglind N, Wilson RC, New MI. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 2007; 92: 137-42. Nordenstrom A, Ahmed S, Jones J et al. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Horm. Res. 2005; 63: 22-8. Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH. Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 2001; 108: 1320-4. Dittrich C, Sevelda P, Salzer H et al. Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin. Eur. J. Cancer 2003; 39: 1129-40. Peter S, McDigean G, Sandiford P, Smith T. Congenital adrenal hyperplasia in the Bahamas due to 21-hydroxylase deficiency. West Indian Med. J. 2006; 55: 110-12. Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. J. Clin. Endocrinol. Metab. 2002; 87: 4106-10. Balsamo A, Cacciari E, Piazzi S et al. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Pediatrics 1996; 98: 362-7. Jeske YWA, McGown IN, Harris M et al. 21-hydroxylase genotyping in Australasian patients with congenital adrenal hyperplasia. J. Pediatr. Endocrinol. 2009; 22: 127-41. Prader A. [Perfect male external genital development and salt-loss syndrome in girls with congenital adrenogenital syndrome.]. Helv. Paediatr. Acta 1958; 13: 5-14. Speiser PW. Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia. Horm. Res. 2007; 68 (Suppl. 5): 90-2. Gleeson HK, Wiley V, Wilcken B et al. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia. J. Paediatr. Child Health 2008; 44: 554-9. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101: 583-90. Strnadova KA, Votava F, Lebl J et al. Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. Eur. J. Pediatr. 2007; 166: 1-4. Liivak K, Tobi S, Schlecht H, Tillmann V. Incidence of classical 21-hydroxylase deficiency and distribution of CYP21A2 mutations in Estonia. Horm. Res. 2008; 69: 227-32. Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J. Pediatr. 1995; 126: 118-21. Torok D, Eckhardt G, Solyom J. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary. Eur. J. Pediatr. 2003; 162: 844-9. Kovacs J, Votava F, Heinze G et al. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J. Clin. Endocrinol. Metab. 2001; 86: 2958-64. Miller WL. Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1994; 78: 241-6. Silveira EL, dos Santos EP, Bachega TAS, van der Linden Nader I, Gross JL, Elnecave RH. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred - an estimate based on a public neonatal screening program in the state of Goias. J. Pediatr. Endocrinol. 2008; 21: 455-60. Bhaskaran S, Nair V, Kumar H, Jayakumar RV. Audit of care of patients with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency in a referral hospital in South India. Indian Pediatr. 2006; 43: 419-23. Thil'en A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1998; 101: E11. Gozzi TG, Harris NP, McGown IN et al. Autopsy diagnosis of 21-hydroxylase deficiency CAH in a case of apparent SIDS. Pediatr. Dev. Pathol. 2005; 8: 397-401. Donaldson MD, Thomas PH, Love JG, Murray GD, McNinch AW, Savage DC. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. Arch. Dis. Child. 1994; 70: 214-18. 2009; 22 2010; 109 2006; 55 1958; 13 2007; 166 2005; 63 2007; 92 2003; 39 2001; 108 1996; 98 2001; 86 1991; 6 2006; 43 2005; 8 2002; 87 2003; 162 2008; 69 1999; 153 1994; 78 1995; 126 2008; 21 2008; 44 1994; 70 1988; 81 1998; 101 2007; 67 2007; 68 e_1_2_5_26_2 e_1_2_5_27_2 e_1_2_5_24_2 e_1_2_5_25_2 e_1_2_5_22_2 e_1_2_5_23_2 e_1_2_5_20_2 e_1_2_5_21_2 Bhaskaran S (e_1_2_5_14_2) 2006; 43 e_1_2_5_28_2 e_1_2_5_29_2 Pang SY (e_1_2_5_3_2) 1988; 81 e_1_2_5_13_2 e_1_2_5_9_2 e_1_2_5_16_2 e_1_2_5_8_2 e_1_2_5_15_2 Balsamo A (e_1_2_5_4_2) 1996; 98 e_1_2_5_7_2 e_1_2_5_10_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_11_2 e_1_2_5_2_2 e_1_2_5_18_2 e_1_2_5_17_2 e_1_2_5_19_2 Prader A (e_1_2_5_12_2) 1958; 13 |
References_xml | – volume: 21 start-page: 455 year: 2008 end-page: 60 article-title: The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred – an estimate based on a public neonatal screening program in the state of Goias publication-title: J. Pediatr. Endocrinol. – volume: 81 start-page: 866 year: 1988 end-page: 74 article-title: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency publication-title: Pediatrics – volume: 162 start-page: 844 year: 2003 end-page: 9 article-title: Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary publication-title: Eur. J. Pediatr. – volume: 69 start-page: 227 year: 2008 end-page: 32 article-title: Incidence of classical 21‐hydroxylase deficiency and distribution of CYP21A2 mutations in Estonia publication-title: Horm. Res. – volume: 92 start-page: 137 year: 2007 end-page: 42 article-title: Aldosterone‐to‐renin ratio as a marker for disease severity in 21‐hydroxylase deficiency congenital adrenal hyperplasia publication-title: J. Clin. Endocrinol. Metab. – volume: 87 start-page: 4106 year: 2002 end-page: 10 article-title: High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland publication-title: J. Clin. Endocrinol. Metab. – volume: 153 start-page: 1272 year: 1999 end-page: 8 article-title: Effect of newborn screening for congenital adrenal hyperplasia publication-title: Arch. Pediatr. Adolesc. Med. – volume: 98 start-page: 362 year: 1996 end-page: 7 article-title: Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia‐Romagna region of Italy, 1980–1995 publication-title: Pediatrics – volume: 108 start-page: 1320 year: 2001 end-page: 4 article-title: Newborn screening for congenital adrenal hyperplasia in the Netherlands publication-title: Pediatrics – volume: 67 start-page: 284 year: 2007 end-page: 91 article-title: How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? publication-title: Horm. Res. – volume: 109 start-page: 148 year: 2010 end-page: 55 article-title: Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21‐hydroxylase deficiency in the pre‐screening era publication-title: J. Formos. Med. Assoc. – volume: 126 start-page: 118 year: 1995 end-page: 21 article-title: Newborn screening for congenital adrenal hyperplasia in New Zealand publication-title: J. Pediatr. – volume: 63 start-page: 22 year: 2005 end-page: 8 article-title: Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening publication-title: Horm. Res. – volume: 39 start-page: 1129 year: 2003 end-page: 40 article-title: Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10‐year results of a prospective randomised phase III study comparing carboplatin‐cisplatin with cyclophosphamide‐cisplatin publication-title: Eur. J. Cancer – volume: 70 start-page: 214 year: 1994 end-page: 18 article-title: Presentation, acute illness, and learning difficulties in salt wasting 21‐hydroxylase deficiency publication-title: Arch. Dis. Child. – volume: 43 start-page: 419 year: 2006 end-page: 23 article-title: Audit of care of patients with congenital adrenal hyperplasia due to 21‐Hydroxylase deficiency in a referral hospital in South India publication-title: Indian Pediatr. – volume: 6 start-page: 306 year: 1991 end-page: 12 article-title: Learning disabilities in children with congenital adrenal hyperplasia publication-title: J. Child Neurol. – volume: 8 start-page: 397 year: 2005 end-page: 401 article-title: Autopsy diagnosis of 21‐hydroxylase deficiency CAH in a case of apparent SIDS publication-title: Pediatr. Dev. Pathol. – volume: 86 start-page: 2958 year: 2001 end-page: 64 article-title: Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries publication-title: J. Clin. Endocrinol. Metab. – volume: 55 start-page: 110 year: 2006 end-page: 12 article-title: Congenital adrenal hyperplasia in the Bahamas due to 21‐hydroxylase deficiency publication-title: West Indian Med. J. – volume: 68 start-page: 90 issue: 5 year: 2007 end-page: 2 article-title: Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia publication-title: Horm. Res. – volume: 78 start-page: 241 year: 1994 end-page: 6 article-title: Clinical review 54: genetics, diagnosis, and management of 21‐hydroxylase deficiency publication-title: J. Clin. Endocrinol. Metab. – volume: 13 start-page: 5 year: 1958 end-page: 14 article-title: [Perfect male external genital development and salt‐loss syndrome in girls with congenital adrenogenital syndrome.] publication-title: Helv. Paediatr. Acta – volume: 101 start-page: E11 year: 1998 article-title: Benefits of neonatal screening for congenital adrenal hyperplasia (21‐hydroxylase deficiency) in Sweden publication-title: Pediatrics – volume: 44 start-page: 554 year: 2008 end-page: 9 article-title: Two‐year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia publication-title: J. Paediatr. Child Health – volume: 101 start-page: 583 year: 1998 end-page: 90 article-title: Results of screening 1.9 million Texas newborns for 21‐hydroxylase‐deficient congenital adrenal hyperplasia publication-title: Pediatrics – volume: 22 start-page: 127 year: 2009 end-page: 41 article-title: 21‐hydroxylase genotyping in Australasian patients with congenital adrenal hyperplasia publication-title: J. Pediatr. Endocrinol. – volume: 166 start-page: 1 year: 2007 end-page: 4 article-title: Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria publication-title: Eur. J. Pediatr. – ident: e_1_2_5_24_2 doi: 10.1001/archpedi.153.12.1272 – ident: e_1_2_5_8_2 doi: 10.1542/peds.108.6.1320 – ident: e_1_2_5_15_2 doi: 10.1007/s00431-003-1311-y – ident: e_1_2_5_19_2 doi: 10.1007/s10024-005-0004-0 – ident: e_1_2_5_5_2 doi: 10.1542/peds.101.4.583 – ident: e_1_2_5_18_2 doi: 10.1542/peds.101.4.e11 – ident: e_1_2_5_20_2 doi: 10.1159/000098400 – ident: e_1_2_5_11_2 doi: 10.1111/j.1440-1754.2008.01383.x – volume: 81 start-page: 866 year: 1988 ident: e_1_2_5_3_2 article-title: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency publication-title: Pediatrics contributor: fullname: Pang SY – ident: e_1_2_5_9_2 doi: 10.1007/s00431-006-0154-8 – ident: e_1_2_5_27_2 doi: 10.1210/jc.78.2.241 – ident: e_1_2_5_28_2 doi: 10.1136/adc.70.3.214 – ident: e_1_2_5_10_2 doi: 10.1515/JPEM.2008.21.5.455 – ident: e_1_2_5_22_2 doi: 10.1016/S0022-3476(95)70513-9 – ident: e_1_2_5_23_2 doi: 10.1159/000113023 – ident: e_1_2_5_7_2 doi: 10.1515/JPEM.2009.22.2.127 – ident: e_1_2_5_2_2 doi: 10.1016/S0959-8049(03)00152-7 – ident: e_1_2_5_6_2 doi: 10.1210/jc.2006-0964 – volume: 98 start-page: 362 year: 1996 ident: e_1_2_5_4_2 article-title: Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia‐Romagna region of Italy, 1980–1995 publication-title: Pediatrics contributor: fullname: Balsamo A – volume: 43 start-page: 419 year: 2006 ident: e_1_2_5_14_2 article-title: Audit of care of patients with congenital adrenal hyperplasia due to 21‐Hydroxylase deficiency in a referral hospital in South India publication-title: Indian Pediatr. contributor: fullname: Bhaskaran S – volume: 13 start-page: 5 year: 1958 ident: e_1_2_5_12_2 article-title: [Perfect male external genital development and salt‐loss syndrome in girls with congenital adrenogenital syndrome.] publication-title: Helv. Paediatr. Acta contributor: fullname: Prader A – ident: e_1_2_5_26_2 doi: 10.1210/jc.2002-012093 – ident: e_1_2_5_25_2 doi: 10.1210/jc.86.7.2958 – ident: e_1_2_5_29_2 doi: 10.1177/088307389100600404 – ident: e_1_2_5_17_2 doi: 10.1016/S0929-6646(10)60035-6 – ident: e_1_2_5_13_2 doi: 10.1159/000082896 – ident: e_1_2_5_21_2 doi: 10.1159/000110586 – ident: e_1_2_5_16_2 doi: 10.1590/S0043-31442006000200009 |
SSID | ssj0002558 |
Score | 2.1097498 |
Snippet | Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal... To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal... Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal... Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal... AIMTo evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1029 |
SubjectTerms | Adolescent Adrenal glands Adrenal Hyperplasia, Congenital - epidemiology Adrenal Hyperplasia, Congenital - ethnology Adrenal Hyperplasia, Congenital - physiopathology Child Child, Preschool Confidence Intervals congenital adrenal hyperplasia Congenital diseases Ethnicity Female Gender Humans Incidence Male newborn screening Oceanic Ancestry Group Retrospective Studies Sex Distribution Western Australia Western Australia - epidemiology Young Adult |
Title | Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period |
URI | https://api.istex.fr/ark:/67375/WNG-STW9HB5K-9/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1440-1754.2012.02584.x https://www.ncbi.nlm.nih.gov/pubmed/23039988 https://www.proquest.com/docview/1132869430/abstract/ https://search.proquest.com/docview/1141538526 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NRZp4YWzjI6NMnjTxliofzkcfoYJVTEMIWrVvlh3bgCqlqB8S8Ndz56QZRTxMaC9JlDhf5zv7d_bdzwA_Ex0obSPuy8hyn2sufdlNYj-2iVUKa1xV0RYXaX_Iz8fJuI5_olyYih-iGXAjy3DtNRm4VPNXRk7zkpkbGqEhvQg70w7hSeLVI3x09ZdJCpFznRWHX5SHwXpQz5sPWuupNkjoD2_B0HVU67qls08wWf1QFY0y6SwXqlM8veJ6_D9_vA1bNXplx5W6fYYPpvwCH__U8_NfYX66uC3vCiZLzW7cInVstQILtkfsrmTETDFnU8vQD8cStGQJk5RNjvtb9Iln9y6vk4qOKhIH1gzHMAo3ZZJFIXtEA2VE0jzVOzA8Ox30-n69rINfcERfPo9lmOlA5xpbC25DGyiERcqkqohiI4kgMDHWoN-ImhKkikjqJNHyZ2mo0UONd6FVTkuzDywwCq3c4lYanqE0pMyKLjpdqGUa3-FBuKpCcV-xd4iXXg_HY5SmIGkKJ03x4MGRq-vmBjmbUPRblojRxS9xPRh1-yfJb9H1oL1SBlEb_hwfHUd5Spz2HvxoLqPJ0jyMLM10SWU49TNJlHqwVylR8zL0CBEy5rkHqVOFf_5scX7Zo6Nv773xADbpdJVn2YbWYrY0hwi4Fuq7M6VnPJoZrw |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB5VILW9lD5pgLZGqnrLKg87yR4BQZfXCtFFy82yY7sgqizahwT8emacbMoiDlXFJYkUJ07GM_bMeOYbgO_CRNq4hIcqcTzkhqtQdUUapk44rXHEdR1t0c96Z_zgXJw35YAoF6bGh2gdbiQZfr4mASeH9CMpp43J3PtGyKeX4GraQYVyGaVfePvq9C-WFOrOTV4cflMRR4thPU--aWGtWiay3zyliC7qtX5h2luBP_NfquNRrjqzqe6Ud4_QHp_pn9_Cm0aBZVs1x72DF7Z6Dy-Pmy36DzDZnV5UlyVTlWG_fZ06Ni_CglMSu6wYgVNM2MgxNMWxBVUtYYoSyvF8gWbx-NqndlLTYY3jwFqPDKOIU6ZYErNblFFGOM0j8xHO9nYHO72wqewQlhwVsJCnKs5NZAqDEwZ3sYs0akbaZrpMUqsII1BYZ9F0RGaJMk04dYqQ-fMsNmikpp9gqRpV9jOwyGoUdIdHZXmO1FAqL7todyGjGewjgHg-hvK6BvCQDw0fjtdITUnUlJ6a8iaAH36w2wfU-IoC4HIhh_2f8tdg2O1ti0PZDWBjzg2ykf0JvjpNioxg7QPYbG-j1NJWjKrsaEZtOC01IskCWK25qO0MjULUGosigMzzwj9_tjw42aGrtf998Bu86g2Oj-TRfv9wHV5TkzrtcgOWpuOZ_YL611R_9XJ1D_z0HdE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NVEK8sC8G2TrmSYi3VPlwPvq4AV2BrUJ8qLxZdmyvqFJa9UNi--t356SBIh6maS9JpDhxcr6zf2ff_QxwkOhAaRtxX0aW-1xz6ctuEvuxTaxS2OKqirYYpP0bfnab3NbxT5QLU_FDNBNuZBmuvyYDn2r7xMhpXTJzUyM0pRfhYNpBPNniaRyRhh9fPlBJIXSu0-Lwk_IwWI_qefZNa0NVi6R-_xwOXYe1blzqvYTx6o-qcJRxZ7lQneL3E7LH__PLr2C7hq_sS6Vvr-GFKd_A5o96gf4tzE8Wo_KuYLLU7KfbpY6ttmDBDondlYyoKeZsYhk64liC9ixhktLJ8TxCp3g2dYmdVHRYsTiwZj6GUbwpkywK2S-0UEYszRO9Aze9k-ujvl_v6-AXHOGXz2MZZjrQucbugtvQBgpxkTKpKqLYSGIITIw16DiiqgSpIpY6Sbz8WRpqdFHjd7BRTkqzBywwCs3c4lEanqE0pMyKLnpdqGYa6_AgXDWhmFb0HeKx28PxGqUpSJrCSVPce3Do2rp5QM7GFP6WJWI4-Caurofd_tfkXHQ9aK-UQdSWP8dXx1GeEqm9B5-b22iztBAjSzNZUhlOA00SpR7sVkrUVIYuIWLGPPcgdarw158tzi6O6Or9vz74CTYvjnvi--ng_ANsUYkq57ING4vZ0nxE8LVQ-86q_gB0IxyA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethnic+and+gender+differences+in+rates+of+congenital+adrenal+hyperplasia+in+Western+Australia+over+a+21+year+period&rft.jtitle=Journal+of+paediatrics+and+child+health&rft.au=Shetty%2C+Vinutha+B&rft.au=Bower%2C+Carol&rft.au=Jones%2C+Timothy+W&rft.au=Lewis%2C+Barry+D&rft.date=2012-11-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1034-4810&rft.eissn=1440-1754&rft.volume=48&rft.issue=11&rft.spage=1029&rft_id=info:doi/10.1111%2Fj.1440-1754.2012.02584.x&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2807544041 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1034-4810&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1034-4810&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1034-4810&client=summon |